Furthermore, tumor-derived MVs have been shown to activate DCs in vivo by delivering tumor DNA triggering intracellular signaling cGAS/STING pathway resulting in potent anti-tumor responses (24–26). This evidence concerns the gene CGAS and neoplasm.